Skip to content

Exploratory biomarker study of APOLLO trial

APOLLO-Bio - APOLLO-Bio

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
JPRN
Registry ID
JPRN-UMIN000039600
Enrollment
200
Registered
2020-02-25
Start date
2020-02-25
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

small cell lung cancer

Interventions

None listed

Sponsors

Wakayama Medical University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Patients who participate APOLLO study and receive informed consent to this APOLLO-Bio study. 2. Patients who can submit enough specimen to be analyzed in this study.

Exclusion criteria

Exclusion criteria: None

Design outcomes

Primary

MeasureTime frame
Not applicable because this is an exploratory biomarker analysis

Countries

Japan

Contacts

Public ContactDaichi Fujimoto

Wakayama Medical University Internal Medicine III

daichianzen@yahoo.co.jp0734410619

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026